Teoxane announces new study reinforcing the biocompatibility, safety and efficacy of RHA®4 in dynamic facial support
A new study by Teoxane confirms the safety, biocompatibility, and efficacy of RHA4 in dynamic facial support. The study shows RHA4's ability to promote rapid collagen formation and support extracellular matrix remodeling, contributing to long-term structural and functional benefits.
SourceTEOXANE·JournalPlastic and Reconstructive Surgery Global Open·TypeRandomized controlled/clinical trial·DateApr 15, 2025